ImpediMed Limited IPDQF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.52M | 2.46M | 2.47M | 2.46M | 2.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.52M | 2.46M | 2.47M | 2.46M | 2.15M |
| Cost of Revenue | 320.50K | 313.40K | 308.50K | 307.50K | 330.50K |
| Gross Profit | 2.20M | 2.15M | 2.16M | 2.15M | 1.82M |
| SG&A Expenses | 4.58M | 4.47M | 4.39M | 4.38M | 4.37M |
| Depreciation & Amortization | 749.00K | 732.30K | 692.10K | 689.90K | 754.90K |
| Other Operating Expenses | 510.50K | 499.10K | 614.00K | 612.10K | 325.70K |
| Total Operating Expenses | 6.20M | 6.06M | 6.03M | 6.01M | 5.81M |
| Operating Income | -3.68M | -3.60M | -3.57M | -3.55M | -3.66M |
| Income Before Tax | -4.48M | -4.38M | -4.03M | -4.01M | -3.87M |
| Income Tax Expenses | 4.30K | 4.20K | 4.60K | 4.60K | 4.80K |
| Earnings from Continuing Operations | -4.48M | -4.38M | -4.03M | -4.02M | -3.87M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.48M | -4.38M | -4.03M | -4.02M | -3.87M |
| EBIT | -3.68M | -3.60M | -3.57M | -3.55M | -3.66M |
| EBITDA | -3.66M | -3.35M | -2.87M | -2.86M | -3.62M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 2.23B | 2.23B | 2.03B | 2.03B | 2.02B |
| Average Diluted Shares Outstanding | 2.23B | 2.23B | 2.03B | 2.03B | 2.02B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |